Back
Black Diamond Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
42
BDTX
Black Diamond Therapeutics
Last Price:
3.26
Seasonality Move:
8.38%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.94 | Buy |
| 20-day SMA: | 3.18 | Buy |
| 50-day SMA: | 4.35 | Sell |
| 200-day SMA: | 4.89 | Sell |
| 8-day EMA: | 3.02 | Buy |
| 20-day EMA: | 3.27 | Sell |
| 50-day EMA: | 3.98 | Sell |
| 200-day EMA: | 4.49 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | 209803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.95 - 3.67) | Sell |
| Bollinger Bands (100): | (3.78 - 5.96) | Sell |
Black Diamond Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.25 while BDTX 8-day simple moving average is 2.94, which is a Buy signal.
- The stock price of BDTX is 3.25 while Black Diamond Therapeutics 20-day SMA is 3.18, which makes it a Buy.
- Black Diamond Therapeutics 50-day simple moving average is 4.35 while BDTX share price is 3.25, making it a Sell technically.
- BDTX stock price is 3.25 and Black Diamond Therapeutics 200-day simple moving average is 4.89, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
42
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $3.25. The Score for BDTX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
183.64M
Price in USD:
3.25
Share Volume:
769.28K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.62
Sell
42
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 3.25 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.25 while BDTX 8-day exponential moving average is 3.02, which is a Buy signal.
- The stock price of BDTX is 3.25 while Black Diamond Therapeutics 20-day EMA is 3.27, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 3.98 while BDTX share price is 3.25, making it a Sell technically.
- BDTX stock price is 3.25 and Black Diamond Therapeutics 200-day simple moving average is 4.49, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.08 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 44.48, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.95 - 3.67), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.78 - 5.96), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.